Loading...
XNAS
IMCC
Market cap6mUSD
Jun 16, Last price  
2.26USD
1D
-7.58%
1Q
29.60%
Name

IM Cannabis Corp

Chart & Performance

D1W1MN
P/E
—
P/S
0.18
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-6.94%
Rev. gr., 5y
42.88%
Revenues
54m
+10.71%
0000000000004,393,0005,197,0009,074,00015,890,00054,300,00054,335,00048,804,00054,031,000
Net income
-11m
L+11.44%
-836,566-611,371-762,399-1,414,259-1,324,125-669,181-519,773-5,374,053-228,344-37,687-45,613-15,750-124,9701,683,000-7,419,000-28,734,000-18,518,000-24,921,000-9,498,000-10,585,000
CFO
-1m
L-86.66%
-290,098-386,294-433,971-1,171,366-527,852-632,559-434,090-218,720-82,884-205,701-26,5960-96,144-46,254-5,959,000-7,919,000-34,372,000-12,640,000-8,075,000-1,077,000
Earnings
Aug 12, 2025

Profile

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
URL
https://imcannabis.com/
IPO date
Oct 21, 1983
Employees
283
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122019‑042018‑042017‑042016‑04
Income
Revenues
54,031
10.71%
48,804
-10.18%
54,335
0.06%
Cost of revenue
58,859
57,990
80,742
Unusual Expense (Income)
NOPBT
(4,828)
(9,186)
(26,407)
NOPBT Margin
Operating Taxes
(1,023)
771
(1,138)
Tax Rate
NOPAT
(3,805)
(9,957)
(25,269)
Net income
(10,585)
11.44%
(9,498)
-61.89%
(24,921)
34.58%
Dividends
Dividend yield
Proceeds from repurchase of equity
944
1,688
3,756
BB yield
-18.14%
-221.31%
-53.66%
Debt
Debt current
17,375
12,573
10,060
Long-term debt
1,070
2,478
3,363
Deferred revenue
Other long-term liabilities
133
254
Net debt
15,951
10,953
8,564
Cash flow
Cash from operating activities
(1,077)
(8,075)
(12,640)
CAPEX
(156)
(581)
(1,562)
Cash from investing activities
(470)
(1,182)
(1,408)
Cash from financing activities
3,825
9,417
4,762
FCF
(4,362)
(4,925)
36,655
Balance
Cash
863
1,813
2,449
Long term investments
1,631
2,285
2,410
Excess cash
1,658
2,142
Stockholders' equity
2,699
4,063
9,290
Invested Capital
21,158
25,957
33,443
ROIC
ROCE
EV
Common stock shares outstanding
2,232
2,136
7,181
Price
2.33
552.97%
0.36
-63.38%
0.97
-97.08%
Market cap
5,203
582.16%
763
-89.10%
7,000
-63.84%
EV
19,057
10,947
16,709
EBITDA
(2,644)
(6,190)
(19,076)
EV/EBITDA
Interest
4,466
3,671
1,972
Interest/NOPBT